Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $5.55 and traded as low as $5.04. Aspen Aerogels shares last traded at $5.2050, with a volume of 949,348 shares changing hands.
Analyst Ratings Changes
A number of brokerages recently commented on ASPN. Barclays lifted their price objective on Aspen Aerogels from $3.00 to $4.00 and gave the stock an “underweight” rating in a research report on Monday, May 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Wall Street Zen upgraded Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Roth Capital reiterated a “buy” rating and issued a $5.75 price target on shares of Aspen Aerogels in a research report on Friday, May 8th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Aspen Aerogels has an average rating of “Hold” and a consensus price target of $5.19.
Aspen Aerogels Price Performance
Aspen Aerogels (NYSE:ASPN – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The firm had revenue of $37.88 million for the quarter, compared to the consensus estimate of $36.58 million. Aspen Aerogels had a negative return on equity of 22.16% and a negative net margin of 48.64%.The firm’s quarterly revenue was down 51.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.06) earnings per share. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. On average, equities research analysts forecast that Aspen Aerogels, Inc. will post -0.8 EPS for the current fiscal year.
Institutional Investors Weigh In On Aspen Aerogels
Institutional investors and hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada lifted its stake in Aspen Aerogels by 84.7% in the first quarter. Royal Bank of Canada now owns 56,419 shares of the construction company’s stock valued at $360,000 after acquiring an additional 25,880 shares during the last quarter. AQR Capital Management LLC acquired a new stake in Aspen Aerogels during the 1st quarter valued at $960,000. Integrated Wealth Concepts LLC bought a new position in Aspen Aerogels during the first quarter worth $84,000. Goldman Sachs Group Inc. boosted its position in Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after purchasing an additional 602,586 shares during the period. Finally, Caxton Associates LLP bought a new stake in shares of Aspen Aerogels during the 1st quarter worth about $307,000. Institutional investors own 97.64% of the company’s stock.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Further Reading
- Five stocks we like better than Aspen Aerogels
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
